European CHMP recommends approval of Palforzia for desensitising children and adolescents to peanut allergy

The active substance is an allergen that is given in increasing amounts to patients with peanut allergy to teach the immune system to tolerate small amount of peanuts. It is taken orally after mixing with soft food, and should be used in conjunction with a peanut-avoidant diet.

Source:

European Medicines Agency